Literature DB >> 27637205

Association between apolipoprotein B EcoRI polymorphisms and coronary heart disease : A meta-analysis.

Yeda Chen1, Jingtang Zeng1, Yiqing Tan1, Min Feng1, Jiheng Qin1, Meihua Lin1, Xiang Zhao1, Xiaolei Zhao1, Yan Liang2, Naizun Zhang2, Shaoqi Rao3.   

Abstract

OBJECTIVE: The study was carried out to examine the association between apolipoprotein B (ApoB) EcoRI polymorphism (E- vs. E+) (rs1042031) and coronary heart disease (CHD) risk by systematically analyzing multiple independent studies.
METHODS: The Hardy-Weinberg equilibrium (HWE) test was applied to assess genotype frequency distribution in healthy controls. The quality of the studies was assessed using the Newcastle-Ottawa scale (NOS). Power analysis was performed with Power and Precision V4 software. A fixed effect model was used because no deviation from homogeneity was found. Publication bias was quantified and examined with Begg's funnel plot test and Egger's linear regression method. The meta-analysis was performed by Stata 12.0 software.
RESULTS: A total of 21 eligible association studies were merged in this meta-analysis and the pooled sample consisted of 2994 CHD patients and 3258 healthy controls. No significant publication bias and heterogeneity were observed in these studies. The pooled odds ratio (OR) and 95% confidence interval (CI) of E- vs. E+ were 1.18 (1.06-1.32). The pooled OR (95% CI) of E+ E- + E- E- vs. E+ E+ was 1.18 (1.04-1.34).
CONCLUSIONS: This meta-analysis indicated that ApoB EcoRI confers a moderate risk for CHD and the E- allele at this locus might be a susceptibility allele for the development of CHD.

Entities:  

Keywords:  Apolipoprotein B; Coronary heart disease; EcoRI polymorphisms; Meta-analysis; Case-control study

Mesh:

Substances:

Year:  2016        PMID: 27637205     DOI: 10.1007/s00508-016-1072-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  31 in total

1.  Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels.

Authors:  R M Corbo; T Vilardo; E Mantuano; M Ruggeri; A T Gemma; R Scacchi
Journal:  Clin Genet       Date:  1997-08       Impact factor: 4.438

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study.

Authors:  P R Turner; P J Talmud; S Visvikis; C Ehnholm; L Tiret
Journal:  Atherosclerosis       Date:  1995-08       Impact factor: 5.162

4.  Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2.

Authors:  Jovana Nikolajevic Starcevic; Marija Santl Letonja; Zala J Praznikar; Jana Makuc; Andreja C Vujkovac; Daniel Petrovic
Journal:  Vasa       Date:  2014-05       Impact factor: 1.961

5.  The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample.

Authors:  M Scartezini; M A Zago; E A Chautard-Freire-Maia; A Pazin-Filho; J A Marin-Neto; J K S Hotta; A J Nascimento; J E Dos-Santos
Journal:  Braz J Med Biol Res       Date:  2003-03-07       Impact factor: 2.590

6.  Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease.

Authors:  J P Pan; A N Chiang; J J Tai; S P Wang; M S Chang
Journal:  Clin Chem       Date:  1995-03       Impact factor: 8.327

7.  DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.

Authors:  J J Genest; J M Ordovas; J R McNamara; A M Robbins; T Meade; S D Cohn; D N Salem; P W Wilson; U Masharani; P M Frossard
Journal:  Atherosclerosis       Date:  1990-05       Impact factor: 5.162

8.  Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer.

Authors:  Yin-Hung Chu; Shu-Ling Tzeng; Chiao-Wen Lin; Ming-Hsien Chien; Mu-Kuan Chen; Shun-Fa Yang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

9.  MTHFR 677C>T polymorphism increases the male infertility risk: a meta-analysis involving 26 studies.

Authors:  Mancheng Gong; Wenjing Dong; Tingyu He; Zhirong Shi; Guiying Huang; Rui Ren; Sichong Huang; Shaopeng Qiu; Runqiang Yuan
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.

Authors:  Petra Disterer; Raya Al-Shawi; Stephan Ellmerich; Simon N Waddington; James S Owen; J Paul Simons; Bernard Khoo
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

View more
  2 in total

Review 1.  Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

Authors:  Lăcrămioara Ionela Butnariu; Laura Florea; Minerva Codruta Badescu; Elena Țarcă; Irina-Iuliana Costache; Eusebiu Vlad Gorduza
Journal:  Life (Basel)       Date:  2022-06-09

2.  Influence of multiple apolipoprotein A-I and B genetic variations on insulin resistance and metabolic syndrome in obstructive sleep apnea.

Authors:  Xinyi Li; Zhihui Fu; Huajun Xu; Jianyin Zou; Huaming Zhu; Zhiqiang Li; Kaiming Su; Hongliang Yi; Jian Guan; Shankai Yin
Journal:  Nutr Metab (Lond)       Date:  2020-09-29       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.